← Leaderboards
Suhas Kallapur
Children'S Hospital Med Ctr (Cincinnati)
$8,325,984
Attributed
$11,945,252
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,945,252 · 8
By mechanism
R01$8,664,016 · 4
UH3$1,907,779 · 1
K08$625,050 · 1
R21$429,000 · 1
UG3$319,407 · 1
Top collaborators
- Sara Bonamo Demauro8 shared
- Susan Hintz8 shared
- Haresh Kirpalani8 shared
- Alan H Jobe4 shared
- Andrew B Herr2 shared
- David A Hildeman2 shared
- Sam Mesiano2 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Chia-Yi Kuan$15,510,472
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungInflammationBaseAnti-Inflammatory AgentsGrantFetusPregnancyFetalExposure ToPremature BirthPremature InfantInflammatoryAmniotic FluidAnimalsClinical TrialsFutureAnimal ModelFetal MembranesInfantPhenotypePreventHuman PathologyBronchopulmonary DysplasiaAffect
Grant awards (32)
Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation$666,882
R01 · FY2025 · HD · contact PI
Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation$696,840
R01 · FY2024 · HD · contact PI
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.$693,743
R01 · FY2023 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$246,511
UH3 · FY2023 · HL
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.$679,641
R01 · FY2022 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$264,047
UH3 · FY2022 · HL
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.$703,958
R01 · FY2021 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2021 · HL
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.$718,324
R01 · FY2020 · HD · contact PI
Transcriptomics and biomarkers of fetal neuroinflammation$267,351
R01 · FY2020 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.$721,511
R01 · FY2019 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$275,728
UH3 · FY2019 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$322,266
UH3 · FY2018 · HL
Novel therapeutic target for intrauterine inflammation$195,000
R21 · FY2018 · HD
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$319,407
UG3 · FY2017 · HL
Novel therapeutic target for intrauterine inflammation$234,000
R21 · FY2017 · HD · contact PI
Mechanisms of Fetal Inflammatory Response Syndrome Induced by Chorioamnionitis$305,767
R01 · FY2013 · HD · contact PI
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease$475,428
R01 · FY2012 · HL
Mechanisms of Fetal Inflammatory Response Syndrome Induced by Chorioamnionitis$312,635
R01 · FY2012 · HD · contact PI
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease$478,516
R01 · FY2011 · HL
Mechanisms of Fetal Inflammatory Response Syndrome Induced by Chorioamnionitis$310,609
R01 · FY2011 · HD · contact PI
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease$489,222
R01 · FY2010 · HL
Mechanisms of Fetal Inflammatory Response Syndrome Induced by Chorioamnionitis$309,264
R01 · FY2010 · HD · contact PI
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease$518,869
R01 · FY2009 · HL
Mechanisms of Fetal Inflammatory Response Syndrome Induced by Chorioamnionitis$315,456
R01 · FY2009 · HD · contact PI
Mechanisms of Vascular Injury in the preterm lung$125,010
K08 · FY2006 · HL · contact PI
Mechanisms of Vascular Injury in the preterm lung$125,010
K08 · FY2005 · HL
Mechanisms of Vascular Injury in the preterm lung$125,010
K08 · FY2004 · HL
Mechanisms of Vascular Injury in the preterm lung$125,010
K08 · FY2003 · HL
Mechanisms of Vascular Injury in the preterm lung$125,010
K08 · FY2002 · HL